👤 Christoph Maack

Regulation of myosin motor extension and conformation is central to cardiac muscle contraction-relaxation, with myosin playing a critical role in mechanosensing during the cardiac cycle. Direct assessment of in vivo dynamic interplay between myosin head position, cross-bridge cycling, sarcomere shortening (filament sliding), muscle stress-strain rates and pressure-volume (PV) relationships is key to understanding both normal cardiac function and ventricle pathological states. This work aims to demonstrate that in vivo temporal regulation of myosin head transfer to actin filaments in systole and diastole has important points of difference from current models based on in vitro and ex vivo muscle studies, particularly in settings of diastolic dysfunction. The first study investigated myosin activation-deactivation in a mouse model of diet-induced obesity (high-fat high-sugar diet) with moderate contraction-relaxation impairment. In a second study myosin regulation was investigated in a novel hypertrophic cardiomyopathy mouse model due to a truncation mutation in the sarcomeric gene encoding cardiac myosin binging protein-C, Mybpc3 (Exon 33 deletion). We demonstrate with in vivo small-angle X-ray scattering (SAXS) simultaneous with PV loop analysis in the beating heart that dynamic regulation of myosin is often non-uniform across the left ventricle from the epicardium to subendocardium, with large differences in myosin head behaviour in both systole and diastole, at least in rodents. Our findings underscore that myosin activation-deactivation is intricately tuned to the mechanical demands of the heart and the work of each myocardial layer. Regional myosin filament dysregulation underpins muscle relaxation impairment, offering new insights into potential therapeutic targets. KEY POINTS: This small-angle X-ray scattering (SAXS) study demonstrates that in vivo myosin activation-deactivation and myosin interfilament spacing vary across myocardial layers and are influenced by diet, exercise and pathological conditions in vivo in the murine heart. During the isovolumetric contraction phase, myosin heads exhibit strong cross-bridge binding in response to mechanical load, which increases in the ejection phase, highlighting the critical role of mechanosensing in early force development. In the absence of myosin binding protein-C within the thick filament complex this strong cross-bridge formation is not sustained during ejection. Impaired myosin cross-bridge detachment likely contributes to sustained cross-bridge activation in the isovolumetric relaxation phase and prolongation of relaxation in hypertrophic cardiomyopathy. This study highlights how disturbed myosin mechanosensing evoked by metabolic stress and genetic mutations can impair myosin motor function and correlates with global cardiac dysfunction. Show less

Hypertrophic cardiomyopathy (HCM) is a prevalent inherited cardiac disorder marked by left ventricular hypertrophy and hypercontractility. This excessive mechanical workload creates an energetic mismatch in which consumption exceeds production, leading to myocardial energy depletion. Although CK (creatine kinase) plays a key role in cardiac energy homeostasis, its involvement in HCM remains unclear. This study investigates how hypercontractility-driven mitochondrial stress and the resulting increase in mitochondrial H CK function was analyzed using myocardial left ventricular tissue from 92 patients with HCM (with and without pathogenic sarcomere variants) and 30 non-failing human controls. Myofilament and mitochondrial CK isoforms were measured using mRNA analysis, protein immunoblotting, enzyme activity assays, mass spectrometry, and redox-sensitive proteomics. To explore links between hypercontractility, mitochondrial reactive oxygen species, and CK dysfunction, we used isolated cardiomyocytes from wild-type, mitochondrial-targeted catalase-overexpressing, CK knockout (myofilament and mitochondrial CK deletion), HCM-associated Our analysis revealed significant reductions in myofilament and mitochondrial CK protein levels, as well as CK activity, in myocardium of patients with HCM, primarily because of oxidative modifications of CK. In isolated mouse cardiomyocytes from wild-type and CK knockouts, hypercontractility induced by EMD-57033 elevated mitochondrial H This study reveals a mechanistic link between hypercontractility, mitochondrial reactive oxygen species, and CK dysfunction in HCM, perpetuating a cycle of energetic dysfunction. Targeting hypercontractility and oxidative stress through myosin inhibition offers a strategy to restore energy balance and reduce arrhythmic risk in HCM. Show less